fig4
![ImmuneScore as a novel RNA-based prognostic signature superior to PD-L1 in advanced non-squamous NSCLC patients receiving chemotherapy combined with immune checkpoint inhibitor therapy](https://image.oaes.cc/cbfa8ca1-48a6-4f3c-807e-c3fc79a72622/jcmt100139.fig.4.jpg)
Figure 4. Construction of prognostic nomogram models. (A) Prognostic nomogram model construction for PFS prediction; (B) ROC curves and corresponding AUCs for variables in predicting PFS; (C) Prognostic nomogram model construction for OS prediction; (D) ROC curves and corresponding AUCs for variables in predicting OS. NSCLC: Non-squamous cell lung cancer; ICI: immune checkpoint inhibitor; PFS: progression-free survival; OS: overall survival.